BibTex RIS Kaynak Göster

Thyrotoxicosis due to functioning metastatic follicular thyroid cancer

Yıl 2016, Cilt: 3 Sayı: 10, 339 - 41, 15.10.2016

Sadiye Altun Tuzcu , Faruk Kilinc , Zafer Pekkolay , Hikmet Soylu Alpaslan Kemal Tuzcu

https://doi.org/10.17546/msd.14352

Öz

Thyrotoxicosis is a common condition associated with excess circulating thyroid hormones. Rarely, thyrotoxicosis can be developing due to functioning metastatic thyroid carcinoma. Most of patients with functional thyroid cancer metastases have had normal thyroxine (T4) concentrations but high serum triiodothyronine (T3-thyrotoxicosis). Inappropriately supressed TSH levels with normal T4 levels may be helpful to suspect T3 thyrotoxicosis. In this case report we present a case of thyrotoxicosis due to metastatic follicular thyroid cancer with a huge metastatic lesion.

Anahtar Kelimeler

metastatic follicular thyroid cancer thyrotoxicosis

Kaynakça

  • Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis. BMJ. 2014; 21:349:g 5128.
  • Nakashima T, Inoue K, Shiro-ozu A, et al. Predominant T3 synthesis in the metastatic thyroid carcinoma in a patient with T3-toxicosis. Metabolismi 1981;30:327-330.
  • Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:593-612.
  • Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab.1997; 82:735-738.
  • Miyauchi A, Takamura Y, Ito Y, et al. 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. J Clin Endocrinol Metab 2008; 93:2239.
  • Kasagi K, Takeuchi R, Miyamoto S, et al. Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases. Clin Endocrinol (Oxf) 1994; 40:429.

Thyrotoxicosis formation due to functioning metastatic follicular thyroid cancer

Yıl 2016, Cilt: 3 Sayı: 10, 339 - 41, 15.10.2016

Sadiye Altun Tuzcu , Faruk Kilinc , Zafer Pekkolay , Hikmet Soylu Alpaslan Kemal Tuzcu

https://doi.org/10.17546/msd.14352

Öz

Kaynakça

  • Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis. BMJ. 2014; 21:349:g 5128.
  • Nakashima T, Inoue K, Shiro-ozu A, et al. Predominant T3 synthesis in the metastatic thyroid carcinoma in a patient with T3-toxicosis. Metabolismi 1981;30:327-330.
  • Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:593-612.
  • Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab.1997; 82:735-738.
  • Miyauchi A, Takamura Y, Ito Y, et al. 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. J Clin Endocrinol Metab 2008; 93:2239.
  • Kasagi K, Takeuchi R, Miyamoto S, et al. Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases. Clin Endocrinol (Oxf) 1994; 40:429.
Toplam 6 adet kaynakça vardır.

Ayrıntılar

Bölüm Vaka Sunumu
Yazarlar

Sadiye Altun Tuzcu

Faruk Kilinc

Zafer Pekkolay

Hikmet Soylu Bu kişi benim

Alpaslan Kemal Tuzcu

Yayımlanma Tarihi 15 Ekim 2016
Yayımlandığı Sayı Yıl 2016 Cilt: 3 Sayı: 10

Kaynak Göster

APA Tuzcu, S. A., Kilinc, F., Pekkolay, Z., Soylu, H., vd. (2016). Thyrotoxicosis due to functioning metastatic follicular thyroid cancer. Medical Science and Discovery, 3(10), 339-41. https://doi.org/10.17546/msd.14352
AMA Tuzcu SA, Kilinc F, Pekkolay Z, Soylu H, Tuzcu AK. Thyrotoxicosis due to functioning metastatic follicular thyroid cancer. Med Sci Discov. Ekim 2016;3(10):339-41. doi:10.17546/msd.14352
Chicago Tuzcu, Sadiye Altun, Faruk Kilinc, Zafer Pekkolay, Hikmet Soylu, ve Alpaslan Kemal Tuzcu. “Thyrotoxicosis Due to Functioning Metastatic Follicular Thyroid Cancer”. Medical Science and Discovery 3, sy. 10 (Ekim 2016): 339-41. https://doi.org/10.17546/msd.14352.
EndNote Tuzcu SA, Kilinc F, Pekkolay Z, Soylu H, Tuzcu AK (01 Ekim 2016) Thyrotoxicosis due to functioning metastatic follicular thyroid cancer. Medical Science and Discovery 3 10 339–41.
IEEE S. A. Tuzcu, F. Kilinc, Z. Pekkolay, H. Soylu, ve A. K. Tuzcu, “Thyrotoxicosis due to functioning metastatic follicular thyroid cancer”, Med Sci Discov, c. 3, sy. 10, ss. 339–41, 2016, doi: 10.17546/msd.14352.
ISNAD Tuzcu, Sadiye Altun vd. “Thyrotoxicosis Due to Functioning Metastatic Follicular Thyroid Cancer”. Medical Science and Discovery 3/10 (Ekim 2016), 339-41. https://doi.org/10.17546/msd.14352.
JAMA Tuzcu SA, Kilinc F, Pekkolay Z, Soylu H, Tuzcu AK. Thyrotoxicosis due to functioning metastatic follicular thyroid cancer. Med Sci Discov. 2016;3:339–41.
MLA Tuzcu, Sadiye Altun vd. “Thyrotoxicosis Due to Functioning Metastatic Follicular Thyroid Cancer”. Medical Science and Discovery, c. 3, sy. 10, 2016, ss. 339-41, doi:10.17546/msd.14352.
Vancouver Tuzcu SA, Kilinc F, Pekkolay Z, Soylu H, Tuzcu AK. Thyrotoxicosis due to functioning metastatic follicular thyroid cancer. Med Sci Discov. 2016;3(10):339-41.
 Kapak Resmi İndir